Dr Pauline Erica Tay is currently Director at the National Health Innovation Centre (NHIC) of the Consortium for Clinical Research and Innovation, Singapore (CRIS), working with public healthcare institutions to facilitate development and commercialisation of healthcare innovations for impact. Prior to this, Pauline was Executive Director and Head of Innovation Partnerships at UBS Tech Connect. Simultaneously, she served as Chairperson of the Singapore Business Federation’s SMEC Subcommittee for Technology, Innovation and Productivity, and Chief Strategy/Operating Officer at Celligenics. Before that, Dr Tay led the Innovation and Enterprise Directorate at the National Research Foundation (NRF) of the Prime Minister’s Office, as Senior Deputy Director, formulating and implementing strategies and programmes to catalyse innovation and enterprise development through technology. Prior to that, she headed the Healthcare and Personal Care cluster at Intellectual Property Intermediary, providing technology and intellectual property intelligence, scouting and matching services to industry. Pauline spent a large part of her early career at the Agency for Science, Technology and Research (A*STAR), assuming roles ranging from basic research and research management, and technology transfer and commercialisation to talent development and international relations. She started her career as a trainer and consultant at the Singapore Productivity and Standards Board (PSB). Dr Tay holds a Ph.D. in Stem Cell Biology and a B.Sc. in Microbiology and Biochemistry from the National University of Singapore, with a postgraduate certificate in Advanced Biotechnology from the Osaka University School of Medicine, Japan.